Cite
APA Citation
Vogel, A., Qin, S., Kudo, M., Hudgens, S., Yamashita, T., Yoon, J., Fartoux, L., Simon, K., López López, C., Sung, M., Dutcus, C., Kraljevic, S., Tamai, T., Grunow, N., Meier, G., & Breder, V. (n.d.). 618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). Annals of oncology, 28, . http://access.bl.uk/ark:/81055/vdc_100097081410.0x000023